市場調査レポート
商品コード
1096458

臨床試験イメージングの世界市場 - 市場規模・状況・予測:2022年~2028年

Global Clinical Trial Imaging Market Size, Status and Forecast 2022-2028

出版日: | 発行: QYResearch | ページ情報: 英文 131 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.86円
臨床試験イメージングの世界市場 - 市場規模・状況・予測:2022年~2028年
出版日: 2022年07月12日
発行: QYResearch
ページ情報: 英文 131 Pages
納期: 2~3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の臨床試験イメージングの市場規模は、2021年の13億7,944万米ドルから、2028年までに21億9,788万米ドルに達し、2022年~2028年の間にCAGRで6.71%の成長が予測されています。

当レポートでは、世界の臨床試験イメージング市場について調査分析し、セグメント別の市場分析、収益・予測 (2017年~2028年) に焦点を当てて、最新の情報を提供しています。

目次

第1章 レポートの概要

  • 調査範囲
  • 市場分析:タイプ別
    • 世界の臨床試験イメージングの市場規模の成長率:タイプ別
    • インハウスイメージングサービス
    • セントラルイメージングサービス
  • 市場:用途別
    • 世界の臨床試験イメージングの市場シェア:用途別
    • 製薬企業
    • バイオテクノロジー企業
    • 学術機関
    • その他
  • 調査目的
  • 対象年

第2章 世界の成長動向

  • 世界の臨床試験イメージング市場の見通し
  • 臨床試験イメージングの成長動向:地域別
  • 臨床試験イメージングの市場力学
    • 臨床試験イメージングの業界動向
    • 臨床試験イメージングの市場促進要因
    • 臨床試験イメージングの市場課題
    • ポーターのファイブフォース分析

第3章 競合情勢:主要企業別

  • 世界の臨床試験イメージングの主要企業:収益別
  • 世界の臨床試験イメージングの市場シェア:企業タイプ別 (ティア1、ティア2、ティア3)
  • 対象企業 - ランキング:臨床試験イメージングの収益別
  • 世界の臨床試験イメージングの市場集中度
  • 臨床試験イメージングの主要企業の本社と提供エリア
  • 臨床試験イメージング市場企業の設立日
  • M&A、拡張計画

第4章 臨床試験イメージングの内訳データ:タイプ別

  • 世界の臨床試験イメージングの過去の市場規模:タイプ別
  • 世界の臨床試験イメージングの市場規模予測:タイプ別

第5章 臨床試験イメージングの内訳データ:用途別

  • 世界の臨床試験イメージングの過去の市場規模:用途別
  • 世界の臨床試験イメージングの市場規模予測:用途別

第6章 北米

  • 北米の臨床試験イメージングの市場規模
  • 北米の臨床試験イメージングの市場規模:タイプ別
  • 北米の臨床試験イメージングの市場規模:用途別
  • 北米の臨床試験イメージングの市場規模:国別
    • 米国
    • カナダ
    • メキシコ

第7章 欧州

  • 欧州の臨床試験イメージングの市場規模
  • 欧州の臨床試験イメージングの市場規模:タイプ別
  • 欧州の臨床試験イメージングの市場規模:用途別
  • 欧州の臨床試験イメージングの市場規模:国別
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア
    • 北欧諸国

第8章 アジア太平洋地域

  • アジア太平洋地域の臨床試験イメージングの市場規模
  • アジア太平洋地域の臨床試験イメージングの市場規模:タイプ別
  • アジア太平洋地域の臨床試験イメージングの市場規模:用途別
  • アジア太平洋地域の臨床試験イメージングの市場規模:地域別
    • 中国
    • 日本
    • 韓国
    • 東南アジア
    • インド
    • オーストラリア

第9章 南米

  • 南米の臨床試験イメージングの市場規模
  • 南米の臨床試験イメージングの市場規模:タイプ別
  • 南米の臨床試験イメージングの市場規模:用途別
  • 南米の臨床試験イメージングの市場規模:国別
    • ブラジル

第10章 中東・アフリカ

  • 中東・アフリカの臨床試験イメージングの市場規模
  • 中東・アフリカの臨床試験イメージングの市場規模:タイプ別
  • 中東・アフリカの臨床試験イメージングの市場規模:用途別
  • 中東・アフリカの臨床試験イメージングの市場規模:国別
    • GCC諸国
    • トルコ
    • 南アフリカ

第11章 主要企業プロファイル

  • CLARIO
  • ICON
  • MCLAREN
  • PAREXEL
  • BIOTELEMETRY
  • PROSCAN IMAGING
  • IMAGING ENDPOINTS
  • RADIANT SAGE
  • MICRON, INC.
  • INTRINSIC IMAGING
  • MEDIAN TECHNOLOGIES
  • CARDIOVASCULAR IMAGING TECHNOLOGIES
  • BANOOK MEDICAL
  • IXICO

第12章 アナリストの見解/結論

第13章 付録

図表

LIST OF TABLES

  • Table 1. Global Clinical Trial Imaging Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
  • Table 2. Global Clinical Trial Imaging Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
  • Table 3. Global Clinical Trial Imaging Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 4. Global Clinical Trial Imaging Market Size by Region (2017-2022) & (US$ Million)
  • Table 5. Global Clinical Trial Imaging Market Share by Region (2017-2022)
  • Table 6. Global Clinical Trial Imaging Forecasted Market Size by Region (2023-2028) & (US$ Million)
  • Table 7. Global Clinical Trial Imaging Market Share by Region (2023-2028)
  • Table 8. Clinical Trial Imaging Market Trends
  • Table 9. Clinical Trial Imaging Market Drivers
  • Table 10. Clinical Trial Imaging Market Challenges
  • Table 11. Global Clinical Trial Imaging Revenue by Players (2017-2022) & (US$ Million)
  • Table 12. Global Clinical Trial Imaging Market Share by Players (2017-2022)
  • Table 13. Global Top Clinical Trial Imaging Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Trial Imaging as of 2021)
  • Table 14. Ranking of Global Top Clinical Trial Imaging Companies by Revenue (US$ Million) in 2021
  • Table 15. Global 5 Largest Players Market Share by Clinical Trial Imaging Revenue (CR5) & (2017-2022)
  • Table 16. Key Players Headquarters and Area Served
  • Table 17. Established Date of Clinical Trial Imaging Market Players
  • Table 18. Mergers & Acquisitions, Expansion Plans
  • Table 19. Global Clinical Trial Imaging Market Size by Type (2017-2022) & (US$ Million)
  • Table 20. Global Clinical Trial Imaging Revenue Market Share by Type (2017-2022)
  • Table 21. Global Clinical Trial Imaging Forecasted Market Size by Type (2023-2028) & (US$ Million)
  • Table 22. Global Clinical Trial Imaging Revenue Market Share by Type (2023-2028)
  • Table 23. Global Clinical Trial Imaging Market Size by Application (2017-2022) & (US$ Million)
  • Table 24. Global Clinical Trial Imaging Revenue Market Share by Application (2017-2022)
  • Table 25. Global Clinical Trial Imaging Forecasted Market Size by Application (2023-2028) & (US$ Million)
  • Table 26. Global Clinical Trial Imaging Revenue Market Share by Application (2023-2028)
  • Table 27. North America Clinical Trial Imaging Market Size by Type (2017-2022) & (US$ Million)
  • Table 28. North America Clinical Trial Imaging Market Size by Type (2023-2028) & (US$ Million)
  • Table 29. North America Clinical Trial Imaging Market Size by Application (2017-2022) & (US$ Million)
  • Table 30. North America Clinical Trial Imaging Market Size by Application (2023-2028) & (US$ Million)
  • Table 31. North America Clinical Trial Imaging Market Size by Country (2017-2022) & (US$ Million)
  • Table 32. North America Clinical Trial Imaging Market Size by Country (2023-2028) & (US$ Million)
  • Table 33. Europe Clinical Trial Imaging Market Size by Type (2017-2022) & (US$ Million)
  • Table 34. Europe Clinical Trial Imaging Market Size by Type (2023-2028) & (US$ Million)
  • Table 35. Europe Clinical Trial Imaging Market Size by Application (2017-2022) & (US$ Million)
  • Table 36. Europe Clinical Trial Imaging Market Size by Application (2023-2028) & (US$ Million)
  • Table 37. Europe Clinical Trial Imaging Market Size by Country (2017-2022) & (US$ Million)
  • Table 38. Europe Clinical Trial Imaging Market Size by Country (2023-2028) & (US$ Million)
  • Table 39. Asia-Pacific Clinical Trial Imaging Market Size by Type (2017-2022) & (US$ Million)
  • Table 40. Asia-Pacific Clinical Trial Imaging Market Size by Type (2023-2028) & (US$ Million)
  • Table 41. Asia-Pacific Clinical Trial Imaging Market Size by Application (2017-2022) & (US$ Million)
  • Table 42. Asia-Pacific Clinical Trial Imaging Market Size by Application (2023-2028) & (US$ Million)
  • Table 43. Asia-Pacific Clinical Trial Imaging Market Size by Region (2017-2022) & (US$ Million)
  • Table 44. Asia-Pacific Clinical Trial Imaging Market Size by Region (2023-2028) & (US$ Million)
  • Table 45. South America Clinical Trial Imaging Market Size by Type (2017-2022) & (US$ Million)
  • Table 46. South America Clinical Trial Imaging Market Size by Type (2023-2028) & (US$ Million)
  • Table 47. South America Clinical Trial Imaging Market Size by Application (2017-2022) & (US$ Million)
  • Table 48. South America Clinical Trial Imaging Market Size by Application (2023-2028) & (US$ Million)
  • Table 49. South America Clinical Trial Imaging Market Size by Country (2017-2022) & (US$ Million)
  • Table 50. South America Clinical Trial Imaging Market Size by Country (2023-2028) & (US$ Million)
  • Table 51. Middle East & Africa Clinical Trial Imaging Market Size by Type (2017-2022) & (US$ Million)
  • Table 52. Middle East & Africa Clinical Trial Imaging Market Size by Type (2023-2028) & (US$ Million)
  • Table 53. Middle East & Africa Clinical Trial Imaging Market Size by Application (2017-2022) & (US$ Million)
  • Table 54. Middle East & Africa Clinical Trial Imaging Market Size by Application (2023-2028) & (US$ Million)
  • Table 55. Middle East & Africa Clinical Trial Imaging Market Size by Country (2017-2022) & (US$ Million)
  • Table 56. Middle East & Africa Clinical Trial Imaging Market Size by Country (2023-2028) & (US$ Million)
  • Table 57. Clario Company Details
  • Table 58. Clario Clinical Trial Imaging Product
  • Table 59. Clario Revenue in Clinical Trial Imaging Business (2017-2022) & (US$ Million)
  • Table 60. Clario Recent Development
  • Table 61. ICON Company Details
  • Table 62. ICON Clinical Trial Imaging Product
  • Table 63. ICON Revenue in Clinical Trial Imaging Business (2017-2022) & (US$ Million)
  • Table 64. ICON Recent Development
  • Table 65. McLaren Company Details
  • Table 66. McLaren Clinical Trial Imaging Product
  • Table 67. McLaren Revenue in Clinical Trial Imaging Business (2017-2022) & (US$ Million)
  • Table 68. McLaren Recent Development
  • Table 69. Parexel Company Details
  • Table 70. Parexel Clinical Trial Imaging Product
  • Table 71. Parexel Revenue in Clinical Trial Imaging Business (2017-2022) & (US$ Million)
  • Table 72. Parexel Recent Development
  • Table 73. BioTelemetry Company Details
  • Table 74. BioTelemetry Clinical Trial Imaging Product
  • Table 75. BioTelemetry Revenue in Clinical Trial Imaging Business (2017-2022) & (US$ Million)
  • Table 76. BioTelemetry Recent Development
  • Table 77. ProScan Imaging Company Details
  • Table 78. ProScan Imaging Clinical Trial Imaging Product
  • Table 79. ProScan Imaging Revenue in Clinical Trial Imaging Business (2017-2022) & (US$ Million)
  • Table 80. ProScan Imaging Recent Development
  • Table 81. Imaging Endpoints Company Details
  • Table 82. Imaging Endpoints Clinical Trial Imaging Product
  • Table 83. Imaging Endpoints Revenue in Clinical Trial Imaging Business (2017-2022) & (US$ Million)
  • Table 84. Imaging Endpoints Recent Development
  • Table 85. Radiant Sage Company Details
  • Table 86. Radiant Sage Clinical Trial Imaging Product
  • Table 87. Radiant Sage Revenue in Clinical Trial Imaging Business (2017-2022) & (US$ Million)
  • Table 88. Micron, Inc. Company Details
  • Table 89. Micron, Inc. Clinical Trial Imaging Product
  • Table 90. Micron, Inc. Revenue in Clinical Trial Imaging Business (2017-2022) & (US$ Million)
  • Table 91. Micron, Inc. Recent Development
  • Table 92. Intrinsic Imaging Company Details
  • Table 93. Intrinsic Imaging Clinical Trial Imaging Product
  • Table 94. Intrinsic Imaging Revenue in Clinical Trial Imaging Business (2017-2022) & (US$ Million)
  • Table 95. Intrinsic Imaging Recent Development
  • Table 96. Median Technologies Company Details
  • Table 97. Median Technologies Clinical Trial Imaging Product
  • Table 98. Median Technologies Revenue in Clinical Trial Imaging Business (2017-2022) & (US$ Million)
  • Table 99. Median Technologies Recent Development
  • Table 100. Cardiovascular Imaging Technologies Company Details
  • Table 101. Cardiovascular Imaging Technologies Clinical Trial Imaging Product
  • Table 102. Cardiovascular Imaging Technologies Revenue in Clinical Trial Imaging Business (2017-2022) & (US$ Million)
  • Table 103. Banook Medical Company Details
  • Table 104. Banook Medical Clinical Trial Imaging Product
  • Table 105. Banook Medical Revenue in Clinical Trial Imaging Business (2017-2022) & (US$ Million)
  • Table 106. Banook Medical Recent Development
  • Table 107. IXICO Company Details
  • Table 108. IXICO Clinical Trial Imaging Product
  • Table 109. IXICO Revenue in Clinical Trial Imaging Business (2017-2022) & (US$ Million)
  • Table 110. IXICO Recent Development
  • Table 111. Research Programs/Design for This Report
  • Table 112. Key Data Information from Secondary Sources
  • Table 113. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Clinical Trial Imaging Picture
  • Figure 2. Global Clinical Trial Imaging Market Share by Type: 2021 VS 2028
  • Figure 3. In-house Imaging Service Market Overview (2017-2022)
  • Figure 4. Central Imaging Service Market Overview (2017-2022)
  • Figure 5. Global Clinical Trial Imaging Market Share by Application: 2021 VS 2028
  • Figure 6. Pharmaceutical Companies Case Studies
  • Figure 7. Biotechnology Companies Case Studies
  • Figure 8. Academic Institutes Case Studies
  • Figure 9. Others Case Studies
  • Figure 10. Clinical Trial Imaging Report Years Considered
  • Figure 11. Global Clinical Trial Imaging Market Size (US$ Million), Year-over-Year: 2017-2028
  • Figure 12. Global Clinical Trial Imaging Market Size, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 13. Global Clinical Trial Imaging Market Share by Region: 2021 VS 2028
  • Figure 14. Porter's Five Forces Analysis
  • Figure 15. Global Clinical Trial Imaging Market Share by Players in 2021
  • Figure 16. The Top 3 and 5 Players Market Share by Clinical Trial Imaging Revenue in 2021
  • Figure 17. North America Clinical Trial Imaging Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 18. North America Clinical Trial Imaging Market Share by Type (2017-2028)
  • Figure 19. North America Clinical Trial Imaging Market Share by Application (2017-2028)
  • Figure 20. North America Clinical Trial Imaging Market Share by Country (2017-2028)
  • Figure 21. United States Clinical Trial Imaging Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 22. Canada Clinical Trial Imaging Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 23. Mexico Clinical Trial Imaging Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 24. Europe Clinical Trial Imaging Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 25. Europe Clinical Trial Imaging Market Share by Type (2017-2028)
  • Figure 26. Europe Clinical Trial Imaging Market Share by Application (2017-2028)
  • Figure 27. Europe Clinical Trial Imaging Market Share by Country (2017-2028)
  • Figure 28. Germany Clinical Trial Imaging Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 29. France Clinical Trial Imaging Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 30. U.K. Clinical Trial Imaging Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 31. Italy Clinical Trial Imaging Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 32. Russia Clinical Trial Imaging Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 33. Nordic Countries Clinical Trial Imaging Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 34. Asia-Pacific Clinical Trial Imaging Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 35. Asia-Pacific Clinical Trial Imaging Market Share by Type (2017-2028)
  • Figure 36. Asia-Pacific Clinical Trial Imaging Market Share by Application (2017-2028)
  • Figure 37. Asia-Pacific Clinical Trial Imaging Market Share by Region (2017-2028)
  • Figure 38. China Clinical Trial Imaging Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 39. Japan Clinical Trial Imaging Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 40. Korea Clinical Trial Imaging Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 41. Southeast Asia Clinical Trial Imaging Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 42. India Clinical Trial Imaging Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 43. Australia Clinical Trial Imaging Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 44. South America Clinical Trial Imaging Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 45. South America Clinical Trial Imaging Market Share by Type (2017-2028)
  • Figure 46. South America Clinical Trial Imaging Market Share by Application (2017-2028)
  • Figure 47. South America Clinical Trial Imaging Market Share by Country (2017-2028)
  • Figure 48. Brazil Clinical Trial Imaging Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 49. Middle East & Africa Clinical Trial Imaging Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 50. Middle East & Africa Clinical Trial Imaging Market Share by Type (2017-2028)
  • Figure 51. Middle East & Africa Clinical Trial Imaging Market Share by Application (2017-2028)
  • Figure 52. Middle East & Africa Clinical Trial Imaging Market Share by Country (2017-2028)
  • Figure 53. GCC Countries Clinical Trial Imaging Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 54. Turkey Clinical Trial Imaging Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 55. South Africa Clinical Trial Imaging Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 56. Clario Revenue Growth Rate in Clinical Trial Imaging Business (2017-2022)
  • Figure 57. ICON Revenue Growth Rate in Clinical Trial Imaging Business (2017-2022)
  • Figure 58. McLaren Revenue Growth Rate in Clinical Trial Imaging Business (2017-2022)
  • Figure 59. Parexel Revenue Growth Rate in Clinical Trial Imaging Business (2017-2022)
  • Figure 60. BioTelemetry Revenue Growth Rate in Clinical Trial Imaging Business (2017-2022)
  • Figure 61. ProScan Imaging Revenue Growth Rate in Clinical Trial Imaging Business (2017-2022)
  • Figure 62. Imaging Endpoints Revenue Growth Rate in Clinical Trial Imaging Business (2017-2022)
  • Figure 63. Radiant Sage Revenue Growth Rate in Clinical Trial Imaging Business (2017-2022)
  • Figure 64. Micron, Inc. Revenue Growth Rate in Clinical Trial Imaging Business (2017-2022)
  • Figure 65. Intrinsic Imaging Revenue Growth Rate in Clinical Trial Imaging Business (2017-2022)
  • Figure 66. Median Technologies Revenue Growth Rate in Clinical Trial Imaging Business (2017-2022)
  • Figure 67. Cardiovascular Imaging Technologies Revenue Growth Rate in Clinical Trial Imaging Business (2017-2022)
  • Figure 68. Banook Medical Revenue Growth Rate in Clinical Trial Imaging Business (2017-2022)
  • Figure 69. IXICO Revenue Growth Rate in Clinical Trial Imaging Business (2017-2022)
  • Figure 70. Bottom-up and Top-down Approaches for This Report
  • Figure 71. Data Triangulation
  • Figure 72. Key Executives Interviewed 113
目次

Market Analysis and Insights:

The global Clinical Trial Imaging market size is projected to reach US$ 2197.88 million by 2028, from US$ 1379.44 million in 2021, at a CAGR of 6.71% during 2022-2028.

Fully considering the economic change by this health crisis, In-house Imaging Service accounting for 30.61% of the Clinical Trial Imaging global market in 2021, is projected to value US$ 598.79 million by 2028, growing at a revised 5.05% CAGR between 2022 and 2028. While Pharmaceutical Companies segment is altered to an 7.33% CAGR throughout this forecast period.

China Clinical Trial Imaging market size was US$ 136.53 million in 2021, while the North America and Europe Clinical Trial Imaging were US$ 459.63 million and US$ 374.96 million, severally. The proportion of the North America was 33.32% in 2021, while China and Europe were 9.90% and 27.18% respectively, and it is predicted that China proportion will reach 11.30% in 2028, trailing a CAGR of 8.54% through the analysis period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Clinical Trial Imaging market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Clinical Trial Imaging market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Clinical Trial Imaging market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Clinical Trial Imaging market.

Scope and Market Size:

Clinical Trial Imaging market is segmented by players, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Clinical Trial Imaging market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2017-2028.

By Company

  • Clario
  • ICON
  • McLaren
  • Parexel
  • BioTelemetry
  • ProScan Imaging
  • Imaging Endpoints
  • Radiant Sage
  • Micron, Inc.
  • Intrinsic Imaging
  • Median Technologies
  • Cardiovascular Imaging Technologies
  • Banook Medical
  • IXICO

Segment by Type

  • In-house Imaging Service
  • Central Imaging Service

Segment by Application

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Academic Institutes
  • Others

By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • Japan
    • India
    • Southeast Asia
    • Korea
    • Australia
    • Rest of Asia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
    • Nordic Countries
    • Rest of Europe
  • South America
    • Brazil
    • Rest of South America
  • Middle East & Africa
    • GCC Countries
    • Turkey
    • South Africa
    • Rest of MEA

TABLE OF CONTENTS

1 REPORT OVERVIEW

  • 1.1 STUDY SCOPE
  • 1.2 MARKET ANALYSIS BY TYPE
    • 1.2.1 GLOBAL CLINICAL TRIAL IMAGING MARKET SIZE GROWTH RATE BY TYPE: 2017 VS 2021 VS 2028
    • 1.2.2 IN-HOUSE IMAGING SERVICE
    • 1.2.3 CENTRAL IMAGING SERVICE
  • 1.3 MARKET BY APPLICATION
    • 1.3.1 GLOBAL CLINICAL TRIAL IMAGING MARKET SHARE BY APPLICATION: 2017 VS 2021 VS 2028
    • 1.3.2 PHARMACEUTICAL COMPANIES
    • 1.3.3 BIOTECHNOLOGY COMPANIES
    • 1.3.4 ACADEMIC INSTITUTES
    • 1.3.5 OTHERS
  • 1.4 STUDY OBJECTIVES
  • 1.5 YEARS CONSIDERED

2 GLOBAL GROWTH TRENDS

  • 2.1 GLOBAL CLINICAL TRIAL IMAGING MARKET PERSPECTIVE (2017-2028)
  • 2.2 CLINICAL TRIAL IMAGING GROWTH TRENDS BY REGION
    • 2.2.1 CLINICAL TRIAL IMAGING MARKET SIZE BY REGION: 2017 VS 2021 VS 2028
    • 2.2.2 CLINICAL TRIAL IMAGING HISTORIC MARKET SIZE BY REGION (2017-2022)
    • 2.2.3 CLINICAL TRIAL IMAGING FORECASTED MARKET SIZE BY REGION (2023-2028)
  • 2.3 CLINICAL TRIAL IMAGING MARKET DYNAMICS
    • 2.3.1 CLINICAL TRIAL IMAGING INDUSTRY TRENDS
    • 2.3.2 CLINICAL TRIAL IMAGING MARKET DRIVERS
    • 2.3.3 CLINICAL TRIAL IMAGING MARKET CHALLENGES
    • 2.3.4 PORTER'橲 FIVE FORCES ANALYSIS

3 COMPETITION LANDSCAPE BY KEY PLAYERS

  • 3.1 GLOBAL TOP CLINICAL TRIAL IMAGING PLAYERS BY REVENUE
    • 3.1.1 GLOBAL TOP CLINICAL TRIAL IMAGING PLAYERS BY REVENUE (2017-2022)
    • 3.1.2 GLOBAL CLINICAL TRIAL IMAGING REVENUE MARKET SHARE BY PLAYERS (2017-2022)
  • 3.2 GLOBAL CLINICAL TRIAL IMAGING MARKET SHARE BY COMPANY TYPE (TIER 1, TIER 2, AND TIER 3)
  • 3.3 PLAYERS COVERED: RANKING BY CLINICAL TRIAL IMAGING REVENUE
  • 3.4 GLOBAL CLINICAL TRIAL IMAGING MARKET CONCENTRATION RATIO
    • 3.4.1 GLOBAL CLINICAL TRIAL IMAGING MARKET CONCENTRATION RATIO (CR5)
    • 3.4.2 GLOBAL TOP 3 AND TOP 5 COMPANIES BY CLINICAL TRIAL IMAGING REVENUE IN 2021
  • 3.5 CLINICAL TRIAL IMAGING KEY PLAYERS HEAD OFFICE AND AREA SERVED
  • 3.6 ESTABLISHED DATE OF CLINICAL TRIAL IMAGING MARKET PLAYERS
  • 3.7 MERGERS & ACQUISITIONS, EXPANSION PLANS

4 CLINICAL TRIAL IMAGING BREAKDOWN DATA BY TYPE

  • 4.1 GLOBAL CLINICAL TRIAL IMAGING HISTORIC MARKET SIZE BY TYPE (2017-2022)
  • 4.2 GLOBAL CLINICAL TRIAL IMAGING FORECASTED MARKET SIZE BY TYPE (2023-2028)

5 CLINICAL TRIAL IMAGING BREAKDOWN DATA BY APPLICATION

  • 5.1 GLOBAL CLINICAL TRIAL IMAGING HISTORIC MARKET SIZE BY APPLICATION (2017-2022)
  • 5.2 GLOBAL CLINICAL TRIAL IMAGING FORECASTED MARKET SIZE BY APPLICATION (2023-2028)

6 NORTH AMERICA

  • 6.1 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE (2017-2028)
  • 6.2 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE
    • 6.2.1 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE (2017-2022)
    • 6.2.2 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE (2023-2028)
    • 6.2.3 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SHARE BY TYPE (2017-2028)
  • 6.3 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION
    • 6.3.1 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION (2017-2022)
    • 6.3.2 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION (2023-2028)
    • 6.3.3 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SHARE BY APPLICATION (2017-2028)
  • 6.4 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY
    • 6.4.1 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY (2017-2022)
    • 6.4.2 NORTH AMERICA CLINICAL TRIAL IMAGING MARKET SHARE BY COUNTRY (2023-2028)
    • 6.4.3 UNITED STATES
    • 6.4.4 CANADA
    • 6.4.5 MEXICO

7 EUROPE

  • 7.1 EUROPE CLINICAL TRIAL IMAGING MARKET SIZE (2017-2028)
  • 7.2 EUROPE CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE
    • 7.2.1 EUROPE CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE (2017-2022)
    • 7.2.2 EUROPE CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE (2023-2028)
    • 7.2.3 EUROPE CLINICAL TRIAL IMAGING MARKET SHARE BY TYPE (2017-2028)
  • 7.3 EUROPE CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION
    • 7.3.1 EUROPE CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION (2017-2022)
    • 7.3.2 EUROPE CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION (2023-2028)
    • 7.3.3 EUROPE CLINICAL TRIAL IMAGING MARKET SHARE BY APPLICATION (2017-2028)
  • 7.4 EUROPE CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY
    • 7.4.1 EUROPE CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY (2017-2022)
    • 7.4.2 EUROPE CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY (2023-2028)
    • 7.4.3 GERMANY
    • 7.4.4 FRANCE
    • 7.4.5 U.K.
    • 7.4.6 ITALY
    • 7.4.7 RUSSIA
    • 7.4.8 NORDIC COUNTRIES

8 ASIA-PACIFIC

  • 8.1 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE (2017-2028)
  • 8.2 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE
    • 8.2.1 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE (2017-2022)
    • 8.2.2 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE (2023-2028)
    • 8.2.3 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SHARE BY TYPE (2017-2028)
  • 8.3 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION
    • 8.3.1 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION (2017-2022)
    • 8.3.2 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION (2023-2028)
    • 8.3.3 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SHARE BY APPLICATION (2017-2028)
  • 8.4 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE BY REGION
    • 8.4.1 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE BY REGION (2017-2022)
    • 8.4.2 ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE BY REGION (2023-2028)
    • 8.4.3 CHINA
    • 8.4.4 JAPAN
    • 8.4.5 KOREA
    • 8.4.6 SOUTHEAST ASIA
    • 8.4.7 INDIA
    • 8.4.8 AUSTRALIA

9 SOUTH AMERICA

  • 9.1 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE (2017-2028)
  • 9.2 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE
    • 9.2.1 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE (2017-2022)
    • 9.2.2 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE (2023-2028)
    • 9.2.3 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SHARE BY TYPE (2017-2028)
  • 9.3 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION
    • 9.3.1 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION (2017-2022)
    • 9.3.2 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION (2023-2028)
    • 9.3.3 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SHARE BY APPLICATION (2017-2028)
  • 9.4 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY
    • 9.4.1 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY (2017-2022)
    • 9.4.2 SOUTH AMERICA CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY (2023-2028)
    • 9.4.3 BRAZIL

10 MIDDLE EAST & AFRICA

  • 10.1 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE (2017-2028)
  • 10.2 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE
    • 10.2.1 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE (2017-2022)
    • 10.2.2 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE BY TYPE (2023-2028)
    • 10.2.3 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SHARE BY TYPE (2017-2028)
  • 10.3 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION
    • 10.3.1 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION (2017-2022)
    • 10.3.2 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE BY APPLICATION (2023-2028)
    • 10.3.3 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SHARE BY APPLICATION (2017-2028)
  • 10.4 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY
    • 10.4.1 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY (2017-2022)
    • 10.4.2 MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE BY COUNTRY (2023-2028)
    • 10.4.3 GCC COUNTRIES
    • 10.4.4 TURKEY
    • 10.4.5 SOUTH AFRICA

11 KEY PLAYERS PROFILES

  • 11.1 CLARIO
    • 11.1.1 CLARIO COMPANY DETAILS
    • 11.1.2 CLARIO BUSINESS OVERVIEW
    • 11.1.3 CLARIO CLINICAL TRIAL IMAGING INTRODUCTION
    • 11.1.4 CLARIO REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022)
    • 11.1.5 CLARIO RECENT DEVELOPMENT
  • 11.2 ICON
    • 11.2.1 ICON COMPANY DETAILS
    • 11.2.2 ICON BUSINESS OVERVIEW
    • 11.2.3 ICON CLINICAL TRIAL IMAGING INTRODUCTION
    • 11.2.4 ICON REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022)
    • 11.2.5 ICON RECENT DEVELOPMENT
  • 11.3 MCLAREN
    • 11.3.1 MCLAREN COMPANY DETAILS
    • 11.3.2 MCLAREN BUSINESS OVERVIEW
    • 11.3.3 MCLAREN CLINICAL TRIAL IMAGING INTRODUCTION
    • 11.3.4 MCLAREN REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022)
    • 11.3.5 MCLAREN RECENT DEVELOPMENT
  • 11.4 PAREXEL
    • 11.4.1 PAREXEL COMPANY DETAILS
    • 11.4.2 PAREXEL BUSINESS OVERVIEW
    • 11.4.3 PAREXEL CLINICAL TRIAL IMAGING INTRODUCTION
    • 11.4.4 PAREXEL REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022)
    • 11.4.5 PAREXEL RECENT DEVELOPMENT
  • 11.5 BIOTELEMETRY
    • 11.5.1 BIOTELEMETRY COMPANY DETAILS
    • 11.5.2 BIOTELEMETRY BUSINESS OVERVIEW
    • 11.5.3 BIOTELEMETRY CLINICAL TRIAL IMAGING INTRODUCTION
    • 11.5.4 BIOTELEMETRY REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022)
    • 11.5.5 BIOTELEMETRY RECENT DEVELOPMENT
  • 11.6 PROSCAN IMAGING
    • 11.6.1 PROSCAN IMAGING COMPANY DETAILS
    • 11.6.2 PROSCAN IMAGING BUSINESS OVERVIEW
    • 11.6.3 PROSCAN IMAGING CLINICAL TRIAL IMAGING INTRODUCTION
    • 11.6.4 PROSCAN IMAGING REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022)
    • 11.6.5 PROSCAN IMAGING RECENT DEVELOPMENT
  • 11.7 IMAGING ENDPOINTS
    • 11.7.1 IMAGING ENDPOINTS COMPANY DETAILS
    • 11.7.2 IMAGING ENDPOINTS BUSINESS OVERVIEW
    • 11.7.3 IMAGING ENDPOINTS CLINICAL TRIAL IMAGING INTRODUCTION
    • 11.7.4 IMAGING ENDPOINTS REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022)
    • 11.7.5 IMAGING ENDPOINTS RECENT DEVELOPMENT
  • 11.8 RADIANT SAGE
    • 11.8.1 RADIANT SAGE COMPANY DETAILS
    • 11.8.2 RADIANT SAGE BUSINESS OVERVIEW
    • 11.8.3 RADIANT SAGE CLINICAL TRIAL IMAGING INTRODUCTION
    • 11.8.4 RADIANT SAGE REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022)
  • 11.9 MICRON, INC.
    • 11.9.1 MICRON, INC. COMPANY DETAILS
    • 11.9.2 MICRON, INC. BUSINESS OVERVIEW
    • 11.9.3 MICRON, INC. CLINICAL TRIAL IMAGING INTRODUCTION
    • 11.9.4 MICRON, INC. REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022)
    • 11.9.5 MICRON, INC. RECENT DEVELOPMENT
  • 11.10 INTRINSIC IMAGING
    • 11.10.1 INTRINSIC IMAGING COMPANY DETAILS
    • 11.10.2 INTRINSIC IMAGING BUSINESS OVERVIEW
    • 11.10.3 INTRINSIC IMAGING CLINICAL TRIAL IMAGING INTRODUCTION
    • 11.10.4 INTRINSIC IMAGING REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022)
    • 11.10.5 INTRINSIC IMAGING RECENT DEVELOPMENT
  • 11.11 MEDIAN TECHNOLOGIES
    • 11.11.1 MEDIAN TECHNOLOGIES COMPANY DETAILS
    • 11.11.2 MEDIAN TECHNOLOGIES BUSINESS OVERVIEW
    • 11.11.3 MEDIAN TECHNOLOGIES CLINICAL TRIAL IMAGING INTRODUCTION
    • 11.11.4 MEDIAN TECHNOLOGIES REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022)
    • 11.11.5 MEDIAN TECHNOLOGIES RECENT DEVELOPMENT
  • 11.12 CARDIOVASCULAR IMAGING TECHNOLOGIES
    • 11.12.1 CARDIOVASCULAR IMAGING TECHNOLOGIES COMPANY DETAILS
    • 11.12.2 CARDIOVASCULAR IMAGING TECHNOLOGIES BUSINESS OVERVIEW
    • 11.12.3 CARDIOVASCULAR IMAGING TECHNOLOGIES CLINICAL TRIAL IMAGING INTRODUCTION
    • 11.12.4 CARDIOVASCULAR IMAGING TECHNOLOGIES REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022)
  • 11.13 BANOOK MEDICAL
    • 11.13.1 BANOOK MEDICAL COMPANY DETAILS
    • 11.13.2 BANOOK MEDICAL BUSINESS OVERVIEW
    • 11.13.3 BANOOK MEDICAL CLINICAL TRIAL IMAGING INTRODUCTION
    • 11.13.4 BANOOK MEDICAL REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022)
    • 11.13.5 BANOOK MEDICAL RECENT DEVELOPMENT
  • 11.14 IXICO
    • 11.14.1 IXICO COMPANY DETAILS
    • 11.14.2 IXICO BUSINESS OVERVIEW
    • 11.14.3 IXICO CLINICAL TRIAL IMAGING INTRODUCTION
    • 11.14.4 IXICO REVENUE IN CLINICAL TRIAL IMAGING BUSINESS (2017-2022)
    • 11.14.5 IXICO RECENT DEVELOPMENT

12 ANALYST'S VIEWPOINTS/CONCLUSIONS

13 APPENDIX

  • 13.1 RESEARCH METHODOLOGY
    • 13.1.1 METHODOLOGY/RESEARCH APPROACH
    • 13.1.2 DATA SOURCE
  • 13.2 DISCLAIMER
  • 13.3 AUTHOR DETAILS